Zanidatamab Monotherapy or Combined with Chemotherapy in HER2-expressing Gastroesophageal Adenocarcinoma: a Phase 1 Trial
Nature communications(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined